Cargando…
Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors
Gastrointestinal stromal tumors (GISTs) with KIT or platelet-derived growth factor receptor alpha (PDGFRa) oncogenic driver gene mutations, respond to tyrosine kinase inhibitors (TKIs) including imatinib, sunitinib, and regorafenib. However, most patients develop TKI resistance; therefore, novel age...
Autores principales: | Na, Young-Soon, Ryu, Min-Hee, Yoo, Changhoon, Lee, Ju-Kyung, Park, Jung Min, Lee, Chae-Won, Lee, Sun Young, Shin, Young-Kyoung, Ku, Ja-Lok, Ahn, Sung-Min, Kang, Yoon-Koo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652737/ https://www.ncbi.nlm.nih.gov/pubmed/29100343 http://dx.doi.org/10.18632/oncotarget.20816 |
Ejemplares similares
-
Establishment of patient-derived xenografts from patients with gastrointestinal stromal tumors: analysis of clinicopathological characteristics related to engraftment success
por: Na, Young-Soon, et al.
Publicado: (2020) -
Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours
por: Yoo, Changhoon, et al.
Publicado: (2019) -
Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer
por: Kang, Jihoon, et al.
Publicado: (2023) -
Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis
por: Yoo, Changhoon, et al.
Publicado: (2016) -
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors
por: Yoo, Changhoon, et al.
Publicado: (2016)